The Centers for Disease Control and Prevention (CDC) has updated and revised its policy on “sensitive but unclassified” (SBU) information, the increasingly common twilight category of information that is neither classified nor publicly released.
“Marking information SBU does not automatically qualify it for a public release exemption,” the CDC policy observes. (There is no “SBU exemption” to the Freedom of Information Act.)
On the other hand, “the absence of the SBU or other related marking does not necessarily mean the information should be publicly released.”
“Therefore, all information should be reviewed and approved prior to its public release,” the CDC instructs.
A copy of the revised SBU policy was posted on the CDC intranet and obtained by Secrecy News.
The Government Accountability Office will publish a major report on the use of Sensitive But Unclassified control markings next month.
Given the unreliability of private market funding for agricultural biotechnology R&D, substantial federal funding through research programs such as AgARDA is vital for accelerating R&D.
“Given the number of existential crises we must collectively confront, I have found policy entrepreneurship to be a fruitful avenue towards doing some of that work.”
We sit on the verge of another Presidential election – an opportunity for meaningful, science-based policy innovations that can appeal to lawmakers on both sides of the aisle.
Outdated Bureau of Labor Statistics classifications hampers the federal government’s ability to design and implement effective policies for emerging technologies sectors.